Model Portfolios | News | Contact

HYLG

Health Care Covered Call & Growth ETF

 

Reasons to Consider HYLG

High Income Potential

HYLG seeks to generate income by writing covered calls on the Health Care Select Sector SPDR Fund.

Upside Potential

By writing calls on 50% of the Health Care Select Sector SPDR Fund, the strategy allows investors to capture half the upside potential of the Health Care Select Sector Index.

Monthly Distributions

HYLG seeks to make distributions on a monthly basis.

Key Information As of 01/24/25

Inception Date 11/21/22
Gross Expense Ratio 0.65%
Net Expense Ratio* 0.60%
Net Assets $3.41 million
NAV $24.38
Fact Sheet View the document

*Fee waivers are contractual and in effect until at least March 1, 2025.


ETF Summary

The Global X Health Care Covered Call & Growth ETF (HYLG) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Health Care Select Sector Index and the Health Care Select Sector SPDR Fund, and “writes” or “sells” corresponding call options on the Health Care Select Sector SPDR Fund representing approximately 50% of the value of HYLG’s portfolio.

ETF Objective

The Global X Health Care Covered Call & Growth ETF (HYLG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P Health Care Select Sector Half BuyWrite Index.

Trading Details As of 01/23/25

Ticker HYLG
Bloomberg Index Ticker BXLVH
CUSIP 37960A750
ISIN US37960A7506
Primary Exchange NYSE Arca
Shares Outstanding 140,000
Number of Holdings 63
30-Day Median Bid-Ask Spread 0.33%

Distributions As of 01/24/25

30-Day SEC Yield 1.17%
Unsubsidized 30-Day SEC Yield 1.12%
Trailing 12-Month Distribution (%) 1 5.28%
Distribution Rate 2 5.10%
Distribution Frequency Monthly

1The distribution as a percentage an investor would have received if they had held the fund over the last twelve months, assuming the most recent NAV. The Trailing 12-Month Distribution (%) is calculated by summing any income, capital gains and return of capital distributions over the past twelve months and dividing by the sum of the most recent NAV and any capital gain distributions made over the same period. The distribution is estimated to include a return of capital. For information on the breakdown of the distributions, please see the “19a Notice” here. These do not imply rates for any future distributions.

2The annual rate an investor would receive if the most recent fund distribution remained the same going forward. The rate represents a single distribution from the fund and does not represent total return of the fund. The distribution rate is calculated by annualizing the most recent distribution and dividing by the most recent fund NAV. The distribution is estimated to include a return of capital. For information on the breakdown of the distributions, please see the “19a Notice” here. These do not imply rates for any future distributions.

ETF Prices As of 01/24/25

NAV $24.38 Daily Change $0.03 0.12%
Market Price $24.39 Daily Change $0.04 0.16%

Performance History

As of recent month & quarter-end (12/31/24)
As of recent month & quarter-end (12/31/24)
Fund NAV Market Price Index
1 Year 1.45% 1.58% 2.35%
Since Inception 3.29% 3.33% 3.69%
1 Year 1.45% 1.58% 2.35%
Since Inception 3.29% 3.33% 3.69%
Year-to-Date 1.45% 1.58% 2.35%
1 Month -5.33% -5.29% -5.24%
3 Months -8.61% -8.36% -8.42%
Since Inception 7.08% 7.17% 7.95%
Year-to-Date 1.45% 1.58% 2.35%
1 Month -5.33% -5.29% -5.24%
3 Months -8.61% -8.36% -8.42%
Since Inception 7.08% 7.17% 7.95%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Options Details As of 01/24/25

Health Care Select Sector SPDR Fund (XLV) Price* 144.31
*Market Price as of 01/24/25

Upside Cap Details

Option Positions Notional Exposure Strike Upside Before Cap Expiration Date Calendar Days to Expiry
Short Health Care Select Sector SPDR Call Option -$1,731,720 141 0.00% 02/21/2025 28

Top Holdings As of 01/24/25

Full Holdings (.csv)
Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
53.85 XLV HEALTH CARE SELECT SECTOR 2371823 144.31 12,735 1,837,787.85
5.62 LLY ELI LILLY & CO 2516152 785.41 244 191,640.04
4.45 UNH UNITEDHEALTH GROUP INC 2917766 532.51 285 151,765.35
3.21 JNJ JOHNSON & JOHNSON 2475833 146.82 746 109,527.72
2.74 ABBV ABBVIE INC B92SR70 170.30 548 93,324.40
2.19 MRK MERCK & CO. INC. 2778844 95.55 782 74,720.10
1.99 TMO THERMO FISHER 2886907 574.82 118 67,828.76
1.96 ABT ABBOTT LABORATORIES 2002305 125.03 534 66,766.02
1.88 ISRG INTUITIVE SURGICAL INC 2871301 584.05 110 64,245.50
1.43 DHR DANAHER CORP 2250870 245.80 198 48,668.40
1.36 BSX BOSTON SCIENTIFIC CORP 2113434 101.94 455 46,382.70
1.35 AMGN AMGEN INC 2023607 275.42 167 45,995.14
1.33 PFE PFIZER INC 2684703 26.09 1,743 45,474.87
1.24 SYK STRYKER CORP 2853688 394.31 107 42,191.17
1.10 BMY BRISTOL-MYERS SQUIBB CO 2126335 59.67 627 37,413.09
1.05 GILD GILEAD SCIENCES INC 2369174 93.07 385 35,831.95
1.04 MDT MEDTRONIC PLC BTN1Y11 90.19 395 35,625.05
1.03 VRTX VERTEX PHARM 2931034 439.62 80 35,169.60
0.83 ELV ELEVANCE HEALTH INC BSPHGL4 400.96 71 28,468.16
0.73 CI THE CIGNA GROUP BHJ0775 293.64 85 24,959.40
0.69 MCK MCKESSON CORP 2378534 591.58 40 23,663.20
0.69 ZTS ZOETIS INC B95WG16 168.61 140 23,605.40
0.63 REGN REGENERON PHARMACEUTICALS 2730190 675.79 32 21,625.28
0.63 CVS CVS HEALTH CORP 2577609 54.55 391 21,329.05
0.62 BDX BECTON DICKINSON AND CO 2087807 243.45 87 21,180.15
0.52 HCA HCA HEALTHCARE INC B4MGBG6 313.07 57 17,844.99
0.43 CASH 1.00 14,504 14,503.67
0.39 COR CENCORA INC 2795393 248.48 54 13,417.92
0.39 A AGILENT TECHNOLOGIES INC 2520153 151.44 88 13,326.72
0.37 EW EDWARDS LIFESCIENCES CORP 2567116 68.99 184 12,694.16
0.37 GEHC GE HEALTHCARE TECHNOLOGY BL6JPG8 88.67 141 12,502.47
0.33 IDXX IDEXX LABORATORIES INC 2459202 435.33 26 11,318.58
0.33 RMD RESMED INC 2732903 250.51 45 11,272.95
0.33 HUM HUMANA INC 2445063 294.63 38 11,195.94
0.33 DXCM DEXCOM INC B0796X4 88.75 126 11,182.50
0.32 IQV IQVIA HOLDINGS INC BDR73G1 204.33 53 10,829.49
0.31 CNC CENTENE CORP 2807061 64.58 161 10,397.38
0.28 CAH CARDINAL HEALTH INC 2175672 128.83 75 9,662.25
0.23 MTD METTLER-TOLEDO 2126249 1,331.10 6 7,986.60
0.23 WST WEST PHARMACEUT 2950482 345.00 23 7,935.00
0.21 WAT WATERS CORP 2937689 411.30 17 6,992.10
0.21 ZBH ZIMMER BIOMET HO 2783815 110.81 63 6,981.03
0.20 LH LABCORP HOLDINGS INC BSBK800 246.00 27 6,642.00
0.19 STE STERIS PLC BFY8C75 217.01 30 6,510.30
0.19 BIIB BIOGEN INC 2455965 146.20 44 6,432.80
0.18 PODD INSULET CORP B1XGNW4 280.35 22 6,167.70
0.17 COO COOPER COS INC/THE BQPDXR3 97.70 60 5,862.00
0.15 HOLX HOLOGIC INC 2433530 71.02 73 5,184.46
0.15 MOH MOLINA HEALTHCARE INC 2212706 304.33 17 5,173.61
0.15 ALGN ALIGN TECHNOLOGY INC 2679204 233.30 22 5,132.60
0.15 DGX QUEST DIAGNOSTICS INC 2702791 155.28 33 5,124.24
0.15 BAX BAXTER INTERNATIONAL INC 2085102 32.45 154 4,997.30
0.14 RVTY REVVITY INC 2305844 123.15 38 4,679.70
0.13 MRNA MODERNA INC BGSXTS3 41.41 104 4,306.64
0.12 VTRS VIATRIS INC BMWS3X9 11.20 365 4,088.00
0.12 INCY INCYTE CORP 2471950 72.59 55 3,992.45
0.11 TECH BIO-TECHNE CORP BSHZ3Q0 77.05 47 3,621.35
0.10 UHS UNIVERSAL HLTH-B 2923785 185.77 18 3,343.86
0.09 SOLV SOLVENTUM CORP BMTQB43 74.99 42 3,149.58
0.09 HSIC HENRY SCHEIN INC 2416962 74.97 40 2,998.80
0.07 TFX TELEFLEX INC 2881407 180.98 14 2,533.72
0.07 CRL CHARLES RIVER LA 2604336 164.97 15 2,474.55
0.07 DVA DAVITA INC 2898087 170.28 14 2,383.92
-0.39 OTHER PAYABLE & RECEIVABLES 1.00 -13,230 -13,229.79
-1.58 2XLV US 02/21/2025 C141 449.99 -120 -53,998.63
Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 12/31/24

Industry Weight (%)
Pharmaceuticals, Biotechnology & Life Sciences 53.9
Health Care Equipment & Services 46.1

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 01/24/25

Return on Equity 20.30%
Weighted Avg. Market Cap 140,077 M
2023 2024
Price-to-earnings 21.62 20.37
Price-to-book value 4.43 3.88

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 12/31/24

Versus Beta
S&P 500 0.57
NASDAQ-100 0.42
MSCI EAFE 0.52
MSCI Emg. Mkts 0.36
Standard Deviation 9.70%

Source: new windowAltaVista Research, LLC

ETF Documents

Investing involves risk, including the possible loss of principal. Concentration in a particular industry or sector will subject HYLG to loss due to adverse occurrences that may affect that industry or sector. Investors in HYLG should be willing to accept a high degree of volatility in the price of the fund’s shares and the possibility of significant losses. The health care industry could be adversely affected by various political, regulatory, supply-and-demand, and other economic factors.

HYLG engages in options trading. An option is a contract sold by one party to another that gives the buyer the right, but not the obligation, to buy (call) or sell (put) a stock at an agreed upon price within a certain period or on a specific date. A covered call option involves holding a long position in a particular asset, in this case U.S. common equities, and writing a call option on that same asset with the goal of realizing additional income from the option premium. By selling covered call options, the fund limits its opportunity to profit from an increase in the price of the underlying index above the exercise price, but continues to bear the risk of a decline in the index. A liquid market may not exist for options held by the fund. While the fund receives premiums for writing the call options, the price it realizes from the exercise of an option could be substantially below the indices current market price. HYLG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. The market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share, and do not represent the returns you would receive if you traded shares at other times. NAVs are calculated using prices as of 4:00 PM Eastern Time. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Cboe, nor does Cboe make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Cboe.